entertainment -WSS

entertainment

author：focus 2025-09-30 00:35:34 - browse：7

Two hands hold a box of four Wegovy pens — first opinion coverage from STAT — Cydni Elledge/The New York Times

The news about anti-obesity drugs keeps getting better. In November, data presented at the American Heart Association meeting added cardiovascular benefit to value in combating obesity and diabetes. This comes on the heels of news that Novo Nordisk halted a clinical trial to test Wegovy’s impact on renal function early because the results they were seeing were so strong.

Yet beneath the hype lies a real fear. Unless we reverse the rising tide of metabolic syndrome, Medicare will be crushed, with tens of millions of Americans having shorter, harder lives. The new drugs offer the first real chance to deploy at scale treatments to halt a seemingly unstoppable trend.

That will be costly. But so is the status quo. Medicare spending on people with advanced metabolic disease is sobering. Beneficiaries with two or more of the costliest conditions — diabetes, heart failure, or chronic kidney disease — comprise just 10% of beneficiaries, according to the NIH’s Renal Data System 2022 Annual Data Report. Yet they account for 25% of total costs. Those with all three conditions are 2% of beneficiaries but almost 7% of costs. And remember, the current cohort of Medicare beneficiaries turned 65 when obesity and diabetes rates were lower, meaning unless we do something dramatic, and fast, these percentages will balloon.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： What we need to know about Arena Bioworks

entertainment

WSS

Titanic submersible: What a 'catastrophic implosion' means and what officials found

Ahead of NATO summit, Biden meets with King Charles for 1st time since coronation

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

FDA drug safety: Singulair case shows systemic surveillance flaws

Cognito secures funding to test medical device for Alzheimer's

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Wikipedia

entertainment

entertainment

Activists slam private health insurers over coverage restrictions

Vertex non

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Juul spent big to court Black leaders to promote its e

Continuity nursing helped my family in our darkest PICU moments

Trump seeks lengthy delay of classified docs trial, citing upcoming election

In Memoriam: Notable people who died in 2023

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Affirmative action in medical school literally saved lives

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

explore

Even great ERs can’t make up for American health disparities

Medicare drug price negotiation’s day in court

UPS workers' union leader explains what's at stake as strike edges closer

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

Readout LOUD podcast: Vertex data, Aduhelm, & Woodcock retires

Titanic submersible victims' family mourns: 'Enormous tragedy and devastation'

focus

entertainment

explore

focus